Clarke Geraldine, Whittemore Alice S
Wellcome Trust Center for Human Genetics, Oxford, UK.
Genet Epidemiol. 2007 Nov;31(7):763-75. doi: 10.1002/gepi.20239.
The family-based admixture mapping test (AMT) identifies disease-related genes using family data from admixed individuals with the disease of interest (cases). The cases' genotypes at a set of markers are used to infer their DNA ancestry as it varies in blocks along the chromosomes. The test compares the cases' inferred ancestries to those expected from their family histories. Deviation between observed and expected ancestries in a region suggests the presence of a disease gene. We use a likelihood-based development of the AMT to compare it with the transmission disequilibrium test (TDT) as applied to admixed populations. The two tests have a common framework but differ significantly when the disease locus is untyped. The TDT infers disease-locus genotypes using the markers with which it is in linkage disequilibrium (LD). In contrast, the AMT infers disease locus ancestries using those of its linked markers. Thus, TDT power depends on LD between disease and marker loci, while AMT power depends on the lengths of the ancestry blocks containing the disease locus. We compare the power of the two tests when applied to cases with descent from two ancestral populations. The AMT outperforms the TDT when case marker ancestries are correctly specified and LD between disease and marker loci is less than one-third its maximal value (Delta' < 1/3). However, the TDT performs better in the presence of uncertain marker ancestries, even for weak LD between disease and marker loci (Delta' = 0.1). These findings have implications for the design of studies using admixed populations.
基于家系的混合映射检验(AMT)利用患有感兴趣疾病(病例)的混合个体的家系数据来识别与疾病相关的基因。一组标记处病例的基因型用于推断其DNA祖先,因为它在染色体上以片段形式变化。该检验将病例推断的祖先与根据其家族史预期的祖先进行比较。一个区域中观察到的和预期的祖先之间的偏差表明存在疾病基因。我们使用基于似然性的AMT发展方法,将其与应用于混合人群的传递不平衡检验(TDT)进行比较。这两种检验有一个共同的框架,但当疾病位点未分型时差异很大。TDT使用与其处于连锁不平衡(LD)状态的标记来推断疾病位点的基因型。相比之下,AMT使用其连锁标记的祖先来推断疾病位点的祖先。因此,TDT的效能取决于疾病和标记位点之间的LD,而AMT的效能取决于包含疾病位点的祖先片段的长度。我们比较了这两种检验应用于有两个祖先群体血统的病例时的效能。当病例标记的祖先被正确指定且疾病和标记位点之间的LD小于其最大值的三分之一(Delta' < 1/3)时,AMT的表现优于TDT。然而,即使疾病和标记位点之间的LD较弱(Delta' = 0.1),在标记祖先不确定的情况下,TDT的表现更好。这些发现对使用混合人群的研究设计有影响。